Evaluation Of Clinical Presentation Of Oral Squamous Cell Carcinoma In A Private Dental Institution
Abarna Jawahar1, G. Maragathavalli2*, Manjari Chaudhary3
1 Department of Oral Medicine and Radiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS),
Saveetha University, Chennai, India.
2 Professor, Department of Oral Medicine and Radiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences
(SIMATS), Saveetha University,Chennai, India.
3 Senior Lecturer, Department of Oral Medicine and Radiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical
Sciences (SIMATS), Saveetha University,Chennai, India.
*Corresponding Author
G. Maragathavalli,
Professor, Department of Oral Medicine and Radiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha
University,Chennai, India.
Tel: 9445171146
E-mail: maragathavalli@saveetha.com
Received: August 11, 2020; Accepted: August 29, 2020; Published: August 30, 2020
Citation:Abarna Jawahar, G. Maragathavalli, Manjari Chaudhary. Evaluation Of Clinical Presentation Of Oral Squamous Cell Carcinoma In A Private Dental Institution. Int J Dentistry Oral Sci. 2020;S4:02:0013:69-74. doi: dx.doi.org/10.19070/2377-8075-SI02-040013
Copyright: G. Maragathavalli© 2020. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Oral cancer is the second most common disease in India with a mortality rate of about 0.3 million deaths per year. Oral squamous
cell carcinoma (OSCC) contributes to 95% of all forms of head and neck cancer. The aim of the study is to evaluate the
clinical presentation of oral squamous cell carcinoma in a private dental institution. A retrospective study was conducted on
patients who visited the Department of Oral Medicine and Oral Oncology during the period June 2019 to March 2020. Case
records of 31 patients who were diagnosed with oral squamous cell carcinoma histopathologically were reviewed. Descriptive
statistics and chi square test was used to evaluate the clinical association between OSCC and age,sex,site and duration of habit.
From the study we found that maximum patients belonged to the age group of 40-50 years (37.50%) and males (71.88%) were
predominantly affected than females (28.13%). About 37.50% of the patients had a habit of smoking or chewing tobacco over
a duration of about 1-5 years and 37.50% had a habit for a duration of about 5-10 years. Ulceroproliferative type (62.50%) was
the most commonly seen clinical type of oral squamous cell carcinoma followed by the ulcerative type (34.38%). The most
commonly affected sites are left buccal mucosa (21.88%), right lower posterior alveolar mucosa (21.88%) and right buccal
mucosa (18.75%). There was statistically no significant association between oral squamous cell carcinoma with age, sex, site
and duration of habit(p value > 0.05).
2.Introduction
3.Materials and Method
4.Results And Discussion
5.Conclusion
6.References
Keywords
Oral Cancer; Oral Carcinoma; Oral Squamous Cell Carcinoma; OSCC.
Introduction
Oral cancer can be defined as a neoplasm involving the oral cavity
which begins at lips and ends at anterior pillar of fauces. Oral
cancer is a seriously growing problem in many parts of the world.
Oral and pharyngeal cancer grouped together is the sixth most
common cancer in the world [38]. Oral cancer is the second most
common disease in India with mortality rate of about 0.3 million
deaths per year [11]. Oral squamous cell carcinoma (OSCC) represents
95% of all forms of head and neck cancer. Its incidence has
increased by 50% in the last decade [23]. Primary oral squamous
cell carcinoma is the most prevalent oral malignancy, but secondary
malignancy from distant sites have also been reported [18, 20].
Majority of the oral carcinomas are related to the use of tobacco
and tobacco products [35, 19]. Smoking or chewing tobacco combined
with alcohol results in increased cancer incidence has an
additive effect because of their synergistic action [37, 30].
Pain may be one of the initial symptoms in oral cancer and is a
common complaint in these patients [32]. The pathognomonic
sign of oral squamous cell carcinoma is the presence of induration
of the margin and the base of the tumour. The high risk
sites for the development of oral squamous cell carcinoma are
the lower buccal sulcus or posterior buccal mucosa followed by
lateral border of tongue and floor of the mouth due to placement
of tobacco containing quid and pooling of tobacco fluid [5, 21]. Radiographically the changes caused due to oral squamous
cell carcinoma may or may not be seen.If there is involvement
of bone, radiographic changes such as bone resorption with illdefined
margins or well-defined margins may be seen [6]. CBCT
has been found to show higher sensitivity for detection of cortical
bone invasion and with a significantly lower exposure dose [24].
The majority of the oral squamous cell carcinoma are diagnosed
at late stage due to lack of awareness which markedly decreases
the chances of their survival and also leads to a significant deterioration
in patient’s quality of life [33, 13]. Treatment options
for oral cancer includes surgery, radiation therapy, targeted drug
therapy and chemotherapy (International Journal of Research in
Pharmaceutical Sciences, no date). Due to the diversity of the
anatomic sites in the neck region and proximity of tumour to
the important vital structures that may be present in that region,
makes the treatment of OSCC more challenging. The dental care
of these patients often requires a multidisciplinary team of surgeons,
radiation oncologists, medical oncologists, nutritionists,
gastroenterologists, speech and swallowing therapists [36]. Despite
the currently available advanced diagnostic and therapeutic
strategies, the disease still remains a challenge for medical and
dental professionals. In some patients there might be poor response
to the treatment and might have recurrence [1]. The fiveyear
survival rate is only 53% and has not improved in the past
decade [34, 29].
Oral cancer and its treatment can cause a range of problems in patients
including difficulty in maintaining their routine oral hygiene
[8, 31]. The management of postoperative pain remains a hideous
task for health-care providers [5]. The main complication of non
surgical treatment of oral cancer is development of oral mucositis.
It is considered as an inherent outcome of chemotherapy or
radiotherapy to the head and neck region in oral cancer patients.
Patients treated with radiotherapy have the oral mucositis prevalence
of about 100 % when compared to those in chemotherapy
treated ones which is about 40% [4]. Radiotherapy (RT) to the
head and neck region can cause salivary gland dysfunction and
xerostomia which increases the risk of dental caries. Hence every
steps should be taken to prevent and manage patients with severe
caries. This can be accomplished through preoperative dental
treatment along with frequent dental evaluation and additional
home care that includes self-applied fluoride [25].
Recently several biomarkers have been identified which can be
used as a diagnostic tool for screening and early detection of oral
cancer. It can also be used to indicate the prognosis of the disease.
Serum lactate dehydrogenase (LDH) levels are significantly
increased in OSCC patients [2, 14]. A range of salivary metabolites
are found to be significantly altered in oral premalignant condition
and in oral squamous cell carcinoma. Salivary biomarkers
such as micro RNA,MMP-9, chemerin, glutathione, malondialdehyde
and tumour necrosis factor (TNF) alpha can be used for
early detection of oral squamous cell carcinoma [15, 16, 9, 26, 28].
The prevalence of oral cancer is higher among elderly males predominantly
with risk habits of betel quid/tobacco chewing and
smoking. Ishiyama et al. (1994) conducted a study on papillary
squamous neoplasm of head and neck, which reported that the
papillary type of squamous neoplasms was highest in age group
of 50-59 years and 60-69 years, males were affected more than
females. Alveolar ridge was the most commonly involved site followed
by buccal mucosa and use of tobacco being the most common
habit [12, 22].
Hence the aim of the study is to evaluate the clinical presentation
of oral squamous cell carcinoma in a private dental institution.
Materials and Methods
A retrospective study was conducted on patients who visited the
Department of Oral Medicine and Oral Oncology during the period
June 2019 to March 2020. Ethical clearance was obtained
from the research committee and the ethical approval number
is SDC/SIHEC/2020/DIASDATA/0619-0320. A primary researcher
and a reviewer were involved in this retrospective study.
Case records of 31 patients who were diagnosed with oral squamous
cell carcinoma histopathologically were reviewed and cross
verification of the case records were done by the primary researcher
and reviewer. In order to minimise the sampling bias, all
the available data on histopathologically confirmed cases of oral
squamous cell carcinoma were included in the study. The following
criteria were followed for the selection of patients.
Inclusion Criteria:
Histopathologically diagnosed oral squamous cell carcinoma patients
who were above the age of 35 years and lesions that were
clinically visible in the oral cavity only were included.
Exclusion Criteria:
Oral squamous cell carcinoma not histopathologically diagnosed
and patients below the age of 35 years were excluded from the
study. Lesions that were not clinically visible in the oral cavity
and patients who had already undergone treatment for oral cancer
were excluded.
After selection of the patient, further information on age, sex,
duration of the tobacco habit, site of the lesion, histopathological
grading of OSCC and clinical presentation was obtained from
an electronic database. The retrieved data was tabulated in SPSS
software and analysed statistically. Descriptive statistics and chi
square test was used to assess the clinical correlation between oral
squamous cell carcinoma with age, sex,site and duration of habit.
Results And Discussion
The study was conducted on 31 patients who were diagnosed with
oral squamous cell carcinoma.
From the study we observe that maximum patients belong to the
age group of 40-50 years (37.50%)(graph 1) and males (71.88%)
were predominantly affected than females (28.13%)(graph 2).
About 37.50% of the patients had a habit of smoking or chewing
tobacco over a duration of about 1-5 years, 37.50% had a habit
for a duration of about 5-10 years and 15.63% had the habit for a
duration of more than 10 years (graph 3).
Ulceroproliferative type (62.50%) was the most commonly seen
clinical type of oral squamous cell carcinoma followed by the ulcerative
type (34.38%) (graph 4).
The most commonly affected sites are left buccal mucosa
(21.88%), right lower posterior alveolar mucosa (21.88%) and
right buccal mucosa (18.75%). Other sites which were affected
are left retromolar region (9.38%), left lateral border of tongue
(9.38%), right retromolar region (6.25%) and right lateral border
of tongue (6.25%) (graph 5).
Well-differentiated oral squamous cell carcinoma contributed to
the majority of the study population (59.38%) followed by moderately
differentiated oral squamous cell carcinoma (34.38%)
(graph 6).
From the study we find that there is no statistically significant association
between oral squamous cell carcinoma with age, sex, site
and duration of habit(p value > 0.05) (graph 7-10).
Study done by Rai HC et al. in 2016 and Mathew PT et al. in
2011 found that there was no statistically significant association
between age and sex with the clinical type of oral squamous cell
carcinoma.This article favours the study findings [7, 17].
According to Soni R et al. there was no statistically significant association
between the duration of tobacco chewing or smoking
habit with the clinical pattern of oral squamous cell carcinoma.
This article supports our study findings [27].
In our study the ulceroproliferative was the most commonly seen
clinical presentation of OSCC, affecting the majority of patients
in the age group of 40-50 years, with a male predilection. The left
buccal mucosa and alveolar mucosa were the most commonly affected
site. The duration of the tobacco habit observed in most
of the patients were minimum of 1 year to a maximum of 10
years.
The limitation of the present study was a relatively small sample
size and study being done retrospectively. Further studies with
an increased sample size can be done prospectively in the future.
Figure 1. The above pie chart represents the age as a baseline characteristics. From this pie chart we can infer that the age group frequently showing distal caries on 2nd molar adjacent to mesioangular impacted mandibular third molar was between 21-30 years (55.9%).
Figure 2. This bar graph represents the gender related baseline characteristics of patients. X axis represents the gender and Y axis represents the frequency of patients. There was a higher incidence of females ( 50.85%) presenting with distal caries on the mandibular 2nd molar adjacent to mesioangular impacted mandibular 3rd molar.
Figure 3. This pie chart depicts the presence of distal caries on 2nd molar adjacent to mesioangularly impacted mandibular third molar. 35.33% patients showed presence of distal caries adjacent to mesioangular mandibular 3rd molar.
Figure 4. The above bar graph depicts the association between the side of lower jaw affected and the incidence of distal caries on the 2nd molar adjacent to mesioangularly impacted mandibular third molar . X- Axis represents the side of the lower jaw frequently affected and Y-Axis represents the incidence of distal caries on the 2nd molar. The Pearson’s Chi Square Test was done to assess the association between side of the lower jaw frequently affected and incidence of distal caries adjacent to mandibular third molar. p > 0.05.
Figure 5. The above pie chart representsposition of mesioangularly impacted mandibular third molar with presence of distal caries on adjacent mandibular second molar. Majority of the patients, 30 Patients (50.85% ) out of 59 patients with distal caries on second molar presented with position A mesioangular 3rd molar.
Figure 6. The above pie chart depicts the ramus relationship of mesioangular impacted mandibular 3rd Molar with presence of distal caries on adjacent mandibular second molar.Higher incidence of distal caries on mandibular 2nd molar was seen in Class 2 Pell and Gregory Ramus Classification of mesioangular impacted mandibular 3rd molar (54.24%).
Figure 7. The above pie chart depicts the ramus relationship of mesioangular impacted mandibular 3rd Molar with presence of distal caries on adjacent mandibular second molar.Higher incidence of distal caries on mandibular 2nd molar was seen in Class 2 Pell and Gregory Ramus Classification of mesioangular impacted mandibular 3rd molar (54.24%).
Figure 8. The above pie chart depicts the ramus relationship of mesioangular impacted mandibular 3rd Molar with presence of distal caries on adjacent mandibular second molar.Higher incidence of distal caries on mandibular 2nd molar was seen in Class 2 Pell and Gregory Ramus Classification of mesioangular impacted mandibular 3rd molar (54.24%).
Figure 9. The above pie chart depicts the ramus relationship of mesioangular impacted mandibular 3rd Molar with presence of distal caries on adjacent mandibular second molar.Higher incidence of distal caries on mandibular 2nd molar was seen in Class 2 Pell and Gregory Ramus Classification of mesioangular impacted mandibular 3rd molar (54.24%).
Figure 10. The above pie chart depicts the ramus relationship of mesioangular impacted mandibular 3rd Molar with presence of distal caries on adjacent mandibular second molar.Higher incidence of distal caries on mandibular 2nd molar was seen in Class 2 Pell and Gregory Ramus Classification of mesioangular impacted mandibular 3rd molar (54.24%).
Conclusion
The present study concludes that there is statistically no significant
association between oral squamous cell carcinoma with age,
sex and duration of habit. However ulceroproliferative(62.50%)
type of oral squamous cell carcinoma was the most predominantly
seen clinical presentation. Maximum patients belonged to the age
group of 40 to 50 years(37.50%) with male predilection (71.88%).
Majority of OSCC patients had a duration of tobacco habit for
a minimum of 1 year to a maximum of 10 years (75%). Future
studies should concentrate on evaluation of hidden predisposing
idiopathic factors associated with oral squamous cell carcinoma.
References
- Bettendorf O, Piffkò J, Bànkfalvi A. Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? Oral Oncol. 2004 Feb;40(2):110-9. Pubmed PMID: 14693233.
- Bharathi, R., N, A. V. and Savitha, G. (2018) ‘Assessment of lipid profile status in oral squamous cell carcinoma patients’, International Journal of Research in Pharmaceutical Sciences. International Journal of Research in Pharmaceutical Sciences, Sponsored by JK Welfare & Pharmascope Foundation, 9(3).
- Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002 Jan;38(1):99-166. Pubmed PMID: 11750846.
- Chaitanya NC, Muthukrishnan A, Babu DBG, Kumari CS, Lakshmi MA, Palat G, Alam KS. Role of Vitamin E and Vitamin A in Oral Mucositis Induced by Cancer Chemo/Radiotherapy- A Meta-analysis. J Clin Diagn Res. 2017 May;11(5):ZE06-ZE09. Pubmed PMID: 28658926.
- Chaitanya NC, Muthukrishnan A, Krishnaprasad CMS, Sanjuprasanna G, Pillay P, Mounika B. An Insight and Update on the Analgesic Properties of Vitamin C. J Pharm Bioallied Sci. 2018 Jul-Sep;10(3):119-125. Pubmed PMID: 30237682.
- Choudhury P, Panigrahi RG, Maragathavalli, Panigrahi A, Patra PC. Vanishing roots: first case report of idiopathic multiple cervico-apical external root resorption. J Clin Diagn Res. 2015 Mar;9(3):ZD17-9. Pubmed PMID: 25954713.
- Rai HC, Ahmed J. Clinicopathological Correlation Study of Oral Squamous Cell Carcinoma in a Local Indian Population. Asian Pac J Cancer Prev. 2016;17(3):1251-4. Pubmed PMID: 27039755.
- Dharman S, Muthukrishnan A. Oral mucous membrane pemphigoid - Two case reports with varied clinical presentation. J Indian Soc Periodontol. 2016 Nov-Dec;20(6):630-634. Pubmed PMID: 29238145.
- Hema Shree K, Ramani P, Sherlin H, Sukumaran G, Jeyaraj G, Don KR, Santhanam A, Ramasubramanian A, Sundar R. Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis. Pathol Oncol Res. 2019 Apr;25(2):447-453. Pubmed PMID: 30712193.
- Neralla M, Jones Jayabalan RG, Rajan J, MP SK, Haque AE, Balasubramaniam A, Christopher PJ. INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES.
- Kadiyala SV. A study of salivary lactate dehydrogenase (Ldh) levels in oral cancer and oral submucosal fibrosis patients amoung the normal individulas. Journal of Pharmaceutical Sciences and Research. 2015 Jul 1;7(7):455.
- Khanolkar VR. Oral cancer in Bombay, India. A review of 1,000 consecutive cases. Cancer Research. 1944 May 1;4(5):313-9.
- Kumar, R. P., Thenmozhi, S. and Thangavelu, L. (2019) ‘Awareness about oral cancer among tobacco users visiting a private dental hospital in Chennai’, Drug Invention Today, 12(3).
- Madhumithaa, S., N, A. V. and Savitha, G. (2018) ‘Serum LDH levels in oral squamous cell carcinoma patients’, International Journal of Research in Pharmaceutical Sciences. International Journal of Research in Pharmaceutical Sciences, Sponsored by JK Welfare & Pharmascope Foundation, 9(3).
- Maheswari TNU, Venugopal A, Sureshbabu NM, Ramani P. Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: A systematic review. Ci Ji Yi Xue Za Zhi. 2018 Apr-Jun;30(2):55-60. Pubmed PMID: 29875583.
- Mariyam Niyas, F. and Savitha, G. (2018) ‘Metabolic Antioxidant Status in Oral Squamous Cell Carcinoma’, Research Journal of Pharmacy and Technology. Research Journal of Pharmacy and Technology, 11(10), pp. 4362–4364.
- Mathur, P. T., Dayal, P. K. and Pai, K. M. (2011) ‘Correlation of Clinical Patterns of Oral Squamous Cell Carcinoma with Age, Site Sex and Habits’. unknown, 23(2), pp. 81–85.
- Misra SR, Shankar YU, Rastogi V, Maragathavalli G. Metastatic hepatocellular carcinoma in the maxilla and mandible, an extremely rare presentation. Contemp Clin Dent. 2015 Mar;6(Suppl 1):S117-21. Pubmed PMID: 25821363.
- Muthukrishnan A, Bijai Kumar L. Actinic cheilosis: early intervention prevents malignant transformation. BMJ Case Rep. 2017 Mar 20;2017:bcr2016218654. Pubmed PMID: 28320702.
- Muthukrishnan A, Bijai Kumar L, Ramalingam G. Medication-related osteonecrosis of the jaw: a dentist's nightmare. BMJ Case Rep. 2016 Apr 6;2016:bcr2016214626. Pubmed PMID: 27053542.
- Muthukrishnan A, Warnakulasuriya S. Oral health consequences of smokeless tobacco use. Indian J Med Res. 2018 Jul;148(1):35-40. Pubmed PMID: 30264752.
- Nandhini, T. and Narayan, V. (2019) ‘Prevalence of oral cancer among patients using different forms of tobacco-A retrospective study’, Drug Invention Today, 11(2).
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. Pubmed PMID: 15761078.
- Patil, S. R. et al. (2018) ‘Three-Rooted Mandibular First Molars in a Saudi Arabian Population: A CBCT Study’, Pesquisa brasileira em odontopediatria e clinica integrada, 18(1), p. 4133.
- Rohini, S. and Kumar, V. J. (2017) ‘Incidence of dental caries and pericoronitis associated with impacted mandibular third molar-A radiographic study’, Journal of advanced pharmaceutical technology & research, 10(4), p. 1081.
- Sabarathinam, J., Selvaraj, J. and Devi, S. (2019) ‘Estimation of Levels of Glutathione Peroxidase (Gpx), Malondialdehyde (Mda), Tumor Necrosis Factor Alpha (Tnf Alpha) and Alpha FetoProtein (Afp) In Saliva of Potentially Malignant Disorders and Oral Squamous Cell Carcinoma’, Biomedical and Pharmacology Journal, 12(04), pp. 1881–1886.
- Shenoi R, Devrukhkar V; Chaudhuri, Sharma BK, Sapre SB, Chikhale A. Demographic and clinical profile of oral squamous cell carcinoma patients: a retrospective study. Indian J Cancer. 2012 Jan-Mar;49(1):21-6. Pubmed PMID: 22842164.
- Sridharan G, Ramani P, Patankar S, Vijayaraghavan R. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Oral Pathol Med. 2019 Apr;48(4):299-306. Pubmed PMID: 30714209.
- Sridharan G, Ramani P, Patankar S. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Cancer Res Ther. 2017 Jul- Sep;13(3):556-561. Pubmed PMID: 28862226.
- Steele JC, Clark HJ, Hong CH, Jurge S, Muthukrishnan A, Kerr AR, Wray D, Prescott-Clements L, Felix DH, Sollecito TP. World Workshop on Oral Medicine VI: an international validation study of clinical competencies for advanced training in oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Aug;120(2):143-51.e7. Pubmed PMID: 25861956.
- Subashri, A. and Maheshwari, T. N. (2016) ‘Knowledge and attitude of oral hygiene practice among dental students’, Research Journal of Pharmacy and Technology. A & V Publications, 9(11), pp. 1840–1842.
- Subha, M. and Arvind, M. (2019) ‘Role of magnetic resonance imaging in evaluation of trigeminal neuralgia with its anatomical correlation’, Biomedical and Pharmacology Journal, 12(1), pp. 289–296.
- Sunar, S., Gayathri, R. and Vishnu Priya, V. (no date) ‘Awareness of smoking and oral cancer among economically backward society – A survey’.
- Varshitha, A. (no date) ‘Prevalence of Oral Cancer in India’.
- Venugopal A, Uma Maheswari TN. Expression of matrix metalloproteinase-9 in oral potentially malignant disorders: A systematic review. J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):474-479. Pubmed PMID: 27721614.
- Wahab, A. P. U. et al. (2017) ‘Comparisons of Clinicopathologic Characteristics among Early and Late Stage of Oral Squamous Cell Carcinoma’, Research journal of pharmaceutical, biological and chemical sciences. Journal of Pharmaceutical Sciences and Research, 9(11), pp. 2147–2150.
- Wangsa D, Ryott M, Avall-Lundqvist E, Petersson F, Elmberger G, Luo J, Ried T, Auer G, Munck-Wikland E. Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma. Br J Cancer. 2008 Oct 7;99(7):1121-8. Pubmed PMID: 18766188.
- Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009 Apr-May;45(4-5):309-16. Pubmed PMID: 18804401.